Challenges and strategies for addressing antibacterial drug resistance in LMICs

IF 69.2 1区生物学 Q1 MICROBIOLOGY

Nature Reviews Microbiology Pub Date : 2024-09-13 DOI:10.1038/s41579-024-01080-8

Ursula Theuretzbacher

引用次数: 0

Abstract

Antibacterial drug resistance is a critical global health issue that affects countries across all economic levels, though it disproportionately affects populations in low- and middle-income countries. Infection and resistance rates vary considerably, necessitating tailored interventions to meet the specific demands of each area. This underscores the need for global solidarity and national accountability in effectively addressing antibacterial drug resistance.

查看原文本刊更多论文

应对低收入和中等收入国家抗菌药物耐药性的挑战和战略

抗菌药物耐药性是一个严重的全球健康问题，影响着各个经济水平的国家，但它对中低收入国家人口的影响尤为严重。感染率和耐药率差异很大，因此需要采取有针对性的干预措施，以满足每个地区的具体需求。这凸显了全球团结和国家问责在有效解决抗菌药物耐药性问题方面的必要性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nature Reviews Microbiology 生物-微生物学

CiteScore

74.00

自引率

0.50%

发文量

149

审稿时长

6-12 weeks

期刊介绍： At Nature Reviews Microbiology, our goal is to become the leading source of reviews and commentaries for the scientific community we cater to. We are dedicated to publishing articles that are not only authoritative but also easily accessible, supplementing them with clear and concise figures, tables, and other visual aids. Our objective is to offer an unparalleled service to authors, referees, and readers, and we continuously strive to maximize the usefulness and impact of each article we publish. With a focus on Reviews, Perspectives, and Comments spanning the entire field of microbiology, our wide scope ensures that the work we feature reaches the widest possible audience.